BR0210099A - Agentes antibacterianos - Google Patents

Agentes antibacterianos

Info

Publication number
BR0210099A
BR0210099A BR0210099-1A BR0210099A BR0210099A BR 0210099 A BR0210099 A BR 0210099A BR 0210099 A BR0210099 A BR 0210099A BR 0210099 A BR0210099 A BR 0210099A
Authority
BR
Brazil
Prior art keywords
formula
antibacterial agents
compounds
useful
preparing compounds
Prior art date
Application number
BR0210099-1A
Other languages
English (en)
Inventor
Edmund Lee Ellsworth
Howard Daniel Hollis Showalter
Kim Marie Hutchings
Dai Quoc Nguyen
Rajeshwar Singh
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority claimed from PCT/IB2002/001598 external-priority patent/WO2002096908A1/en
Publication of BR0210099A publication Critical patent/BR0210099A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"AGENTES ANTIBACTERIANOS". A presente invenção refere-se a compostos com a Fórmula (I): nos quais R~ 1~-R~ 6~ e K assumem qualquer dos valores que são pormenorizados na descrição, e um sal farmaceuticamente aceitável destes, que sejam úteis como agentes antibacterianos. Também são descritas composições farmacêuticas que incluem um ou mais compostos com a fórmula I, processos para preparar compostos com a Fórmula I, e intermediários úteis para preparar compostos com a Fórmula I.
BR0210099-1A 2001-05-30 2002-05-01 Agentes antibacterianos BR0210099A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29433801P 2001-05-30 2001-05-30
US36507702P 2002-03-19 2002-03-19
PCT/IB2002/001598 WO2002096908A1 (en) 2001-05-30 2002-05-01 Antibacterial agents

Publications (1)

Publication Number Publication Date
BR0210099A true BR0210099A (pt) 2004-04-13

Family

ID=31720253

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210099-1A BR0210099A (pt) 2001-05-30 2002-05-01 Agentes antibacterianos

Country Status (11)

Country Link
US (1) US6864259B2 (pt)
EP (1) EP1395585B1 (pt)
JP (1) JP2004532876A (pt)
AT (1) ATE315038T1 (pt)
BR (1) BR0210099A (pt)
DE (1) DE60208541D1 (pt)
HN (1) HN2002000111A (pt)
MX (1) MXPA03010799A (pt)
PE (1) PE20030125A1 (pt)
SV (1) SV2003001058A (pt)
UY (1) UY27311A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10214257A1 (de) * 2002-03-28 2003-10-16 Merck Patent Gmbh Verwendung von kompatiblen Soluten zur Inhibierung der Freisetzung von Ceramiden
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
EP2500022B1 (en) * 2009-11-13 2015-12-16 Microbial Chemistry Research Foundation Antibacterial agent for drug-resistant bacteria and use of same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE8626T1 (de) 1980-03-10 1984-08-15 Berri-Balzac Societe Dite: 3-amino-(1h,3h)-2,4-chinazolindionderivate.
GB2097784A (en) 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
AU5813394A (en) 1992-12-23 1994-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
US5670506A (en) 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
ATE217309T1 (de) 1993-10-14 2002-05-15 Abbott Lab Verbindungen des chinolizinon-typs
WO1998018781A2 (en) 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
EP1028950B1 (en) 1997-10-28 2003-05-02 Warner-Lambert Company LLC 7-substituted quinazolin-2,4-diones useful as antibacterial agents
HUP0102514A3 (en) 1998-05-26 2002-03-28 Warner Lambert Co Pyrido-pyrimidin and pyrimido-pyrimidin derivatives as inhibitors of cellular proliferation and pharmaceutical compositions thereof
BR0017010A (pt) 2000-01-24 2002-11-05 Warner Lambert Co Agentes antibacterianos 3-aminoquinazolin-2,4-diona

Also Published As

Publication number Publication date
SV2003001058A (es) 2003-03-18
ATE315038T1 (de) 2006-02-15
MXPA03010799A (es) 2005-07-25
EP1395585A1 (en) 2004-03-10
HN2002000111A (es) 2002-07-08
PE20030125A1 (es) 2003-02-12
US6864259B2 (en) 2005-03-08
US20030114458A1 (en) 2003-06-19
DE60208541D1 (de) 2006-03-30
EP1395585B1 (en) 2006-01-04
UY27311A1 (es) 2002-12-31
JP2004532876A (ja) 2004-10-28

Similar Documents

Publication Publication Date Title
WO2002102793A3 (en) Quinazolinediones as antibacterial agents
ATE433447T1 (de) Pyrimiidinverbindungen
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
SE0101675D0 (sv) Novel composition
SE0302811D0 (sv) Novel compounds
AU2003228770A8 (en) Substituted pyrazolopyrimidines
ES2243579T3 (es) Derivados de pirazolopirideno.
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
ATE364043T1 (de) Pyrazolo-pyridine für die behandlung von herpes- ansteckungen
SE0302192D0 (sv) Novel compounds
SE0302139D0 (sv) Novel compounds
AP2002002616A0 (en) Antidibetic agents
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
TW200604197A (en) New compounds
MXPA04006041A (es) Antivirales de piridoquinoxalina.
SE0303280D0 (sv) Novel compounds
WO2004087652A3 (en) Imidazotriazine compounds
ATE274515T1 (de) Pyrazolopyridinderivate
SE0302755D0 (sv) Novel compounds
SE0202693D0 (sv) Compounds
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
MXPA04005151A (es) Compuestos terapeuticos.
SE0202692D0 (sv) Compounds
UY27311A1 (es) Agentes antibacterianos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.